nach oben

Acta Diabetologica

Erschienen in:

24.06.2020 | COVID-19 | Review Article Zur Zeit gratis

Diabetes increases the mortality of patients with COVID-19: a meta-analysis

verfasst von: Zeng-hong Wu, Yun Tang, Qing Cheng

Erschienen in: Acta Diabetologica | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Aims

Nowadays, the ongoing pandemic of COVID-19 caused by the novel coronavirus Syndrome-Coronavirus-2 (SARS-CoV-2) is an emerging, rapidly evolving situation. Complications such as hypertension, diabetes, COPD, cardiovascular disease, and cerebrovascular disease are major risk factors for patients with COVID-19.

Methods

No meta-analysis has explored if or not diabetes related to mortality of patients with COVID-19. Therefore, this meta-analysis first aims to explore the possible clinical mortality between diabetes and COVID-19, analyze if diabetes patients infected with SARS-CoV-2 are exposed to the worst clinical prognostic risk, and to evaluate the reliability of the evidence.

Results

Our results showed a close relationship between diabetes and mortality of COVID-19, with a pooled OR of 1.75 (95% CI 1.31–2.36; P = 0.0002). The pooled data were calculated with the fixed effects model (FEM) as no heterogeneity appeared in the studies. Sensitivity analysis showed that after omitting any single study or converting a random effect model to FEM, the main results still held.

Conclusions

Our meta-analysis showed that diabetes increases the mortality of patients with COVID-19. These results indicated the disturbance of blood glucose in the COVID-19 patients. More importantly, this meta-analysis grades the reliability of evidence for further basic and clinical research into the diabetes dysfunction in COVID-19 patients.

Liu Y, Yang Y, Zhang C et al (2020) Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci 63:364–374CrossRefPubMedPubMedCentral

Gorbalenya AE, Baker SC, Baric RS et al (2020) The species severe acute respiratory syndromerelated coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 5(4):536–544. https://doi.org/10.1038/s41564-020-0695-zCrossRef

Ceccarelli M, Berretta M, Venanzi Rullo E, Nunnari G, Cacopardo B (2020) Differences and similarities between severe acute respiratory syndrome (SARS)-coronavirus (CoV) and SARS-CoV-2. Would a rose by another name smell as sweet? Eur Rev Med Pharmacol Sci 24(5):2781–2783. https://doi.org/10.26355/eurrev_202003_20551CrossRefPubMed

Walls AC, Park Y-J, Tortorici MA, Wall A, McGuire AT, Veesler D (2020) Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. https://doi.org/10.1016/j.cell.2020.02.058CrossRefPubMedPubMedCentral

Bindom SM, Lazartigues E (2008) The sweeter side of ACE2: physiological evidence for a role in diabetes. Mol Cell Endocrinol 302(2):193–202CrossRefPubMedPubMedCentral

Du RH, Liu LM, Yin W et al (2020) Hospitalization and critical care of 109 decedents with COVID-19 Pneumonia in Wuhan, China. Ann Am Thorac Soc. https://doi.org/10.1513/AnnalsATS.202003-225OCCrossRefPubMedPubMedCentral

Wang B, Li R, Lu Z et al (2020) Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging (Albany NY). https://doi.org/10.18632/aging.103000CrossRefPubMedCentral

Stan A (2010) Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603–605. https://doi.org/10.1007/s10654-010-9491-zCrossRef

Yang X, Yu Y, Xu J et al (2020) Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. https://doi.org/10.1016/S2213-2600(20)30079-5CrossRefPubMedPubMedCentral

10.

Wang L, He W, Yu X et al (2019) Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. J Infect. https://doi.org/10.1016/j.jinf.2020.03.019CrossRefPubMedPubMedCentral

11.

Chen T, Wu D, Chen H et al (2020) Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 368:m1091. https://doi.org/10.1136/bmj.m1091CrossRefPubMedPubMedCentral

12.

Chen TL, Dai Z, Mo P et al (2020) Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China (2019): a single-centered, retrospective study. J. Gerontol A Biol Sci Med Sci. https://doi.org/10.1093/gerona/glaa089CrossRefPubMedPubMedCentral

13.

Yuan M, Yin W, Tao Z et al (2020) Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China. PLoS ONE 15:e0230548. https://doi.org/10.1371/journal.pone.0230548CrossRefPubMedPubMedCentral

14.

Du R-H, Liang L-R, Yang C-Q et al (2020) Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur Respir J. https://doi.org/10.1183/13993003.00524-2020CrossRefPubMedPubMedCentral

15.

Ruan Q, Yang K, Wang W et al (2020) Correction to: clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. https://doi.org/10.1007/s00134-020-06028-zCrossRefPubMedPubMedCentral

16.

Zhou F, Yu T, Du R et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054–1062. https://doi.org/10.1016/S0140-6736(20)30566-3CrossRefPubMedPubMedCentral

17.

Deng Y, Liu W, Liu K et al (2020) Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study. Chin Med J (Engl). https://doi.org/10.1097/CM9.0000000000000824CrossRefPubMedCentral

18.

Wu Z, McGoogan JM (2020) Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. https://doi.org/10.1001/jama.2020.2648CrossRefPubMedPubMedCentral

19.

Yang JK, Feng Y, Yuan MY et al (2006) Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabet Med 23(6):623–628. https://doi.org/10.1111/j.1464-5491.2006.01861.xCrossRefPubMed

20.

Banik GR, Alqahtani AS, Booy R, Rashid H (2016) Risk factors for severity and mortality in patients with MERS-CoV: analysis of publicly available data from Saudi Arabia. Virol Sin 31(1):81–84. https://doi.org/10.1007/s12250-015-3679-zCrossRefPubMedPubMedCentral

21.

Ghosh A, Gupta R, Misra A et al (2020) Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: guidelines for physicians. Diabetes Metab Syndr 14(4):273–276. https://doi.org/10.1016/j.dsx.2020.04.001CrossRefPubMedPubMedCentral

22.

Knapp S (2013) Diabetes and infection: is there a link? A mini-review. Gerontology 59(2):99–104. https://doi.org/10.1159/000345107CrossRefPubMed

23.

Onodera T, Jenson AB, Yoon JW et al (1978) Virus-induced diabetes mellitus: reovirus infection of pancreatic β cells in mice. Science 201(4355):529–531CrossRefPubMed

24.

Yang J-K, Lin S-S, Ji X-J et al (2010) Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol 47:193–199CrossRefPubMed

25.

Fadini GP, Morieri ML, Longato E, Avogaro A (2020) Prevalence and impact of diabetes among people infected with SARS-CoV-2. J Endocrinol Investig. https://doi.org/10.1007/s40618-020-01236-2CrossRef

26.

Feng Y, Ling Y, Bai T et al (2020) COVID-19 with different severity: a multi-center study of clinical features. Am J Respir Crit Care Med. https://doi.org/10.1164/rccm.202002-0445OCCrossRefPubMedPubMedCentral

27.

Nikolich-Zugich J, Knox KS, Rios CT et al (2020) SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes. Geroscience. https://doi.org/10.1007/s11357-020-00186-0CrossRefPubMedPubMedCentral

28.

Luzi L, Radaelli MG (2020) Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic. Acta Diabetol. https://doi.org/10.1007/s00592-020-01522-8CrossRefPubMedPubMedCentral

Titel: Diabetes increases the mortality of patients with COVID-19: a meta-analysis
verfasst von: Zeng-hong Wu
Yun Tang
Qing Cheng
Publikationsdatum: 24.06.2020
Verlag: Springer Milan
Schlagwort: COVID-19
Erschienen in: Acta Diabetologica / Ausgabe 2/2021
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI: https://doi.org/10.1007/s00592-020-01546-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Aims

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2021

A case of a Rhizopus infection in a patient with diabetes and fear

Use of DPP-4 inhibitors in patients with COVID-19

Left atrial function in diabetes: does it help?

Predictions of diabetes complications and mortality using hba1c variability: a 10-year observational cohort study

Reply to letter to the editor regarding “Use of DPP-4 inhibitors in patients with COVID-19”